| HOME >> BIOLOGY >> TECHNOLOGY |
A prospective clinical trial shows that intravenous N-acetylcysteine (NAC) does not improve survival in pediatric patients with non-Acetaminophen acute liver failure (Abstract #622)
N-acetylcysteine (NAC) is the treatment of choice for patients with Acetaminophen toxicity, especially when associated with liver failure, but a new study shows it does not benefit children with acute liver failure who do not have acute Acetaminophen toxicity. Investigators sought to learn whether NAC would benefit children with acute liver failure that is not caused by Acetaminophen, and whether children given NAC had improved survival at one year, including those who received a liver transplant. Previous studies suggested NAC might be helpful, but investigators found that not only was it not helpful, but children under 2 fared worse than those who received the placebo.
Dr. Squires will present these data on Monday, May 9 at 8:30 a.m. CT in S105, McCormick Place.
Division I College Athletes of the Highest Intensity Sports Have More Functional GI Disorders (Abstract #Su1346)
College athletes involved in the highest intensity sportssuch as crew, lacrosse and swimminghave more functional gastrointestinal disorders than their peers in other sports or general college students. They found that up to 60 percent of athletes on the university's Division 1 crew, lacrosse and swim teams experienced at least one symptom of a gastrointestinal (GI) problem, from constipation or diarrhea to abdominal bloating or pain. By comparison, half of non-athletes and less than 35 percent of athletes across all Drexel teams reported any GI symptom.
Dr. Eva Alsheik will present these data, on Sunday, May 8, at 12:00 p.m. CT in South Hall, McCormick Place.
Experience with the new ultrathin pediatric colonoscope: A case series (Abstract #Sa1608)
Researchers studying a new ultra-thin colonoscope (UT-
'/>"/>
| Contact: Amy Levey alevey@gymr.com 312-791-6715 Digestive Disease Week Source:Eurekalert |